Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Qingre Runzao Decoction is a Traditional Chinese Medicine (TCM) formula developed by the China-Japan Friendship Hospital for the treatment of primary Sjögren's syndrome (pSS). In TCM theory, pSS is often characterized by "Yin deficiency and dryness-heat syndrome," and this decoction is designed to nourish the kidneys (Bushen), clear heat (Qingre), and moisten dryness (Runzao). It is typically administered as an oral decoction. Clinical studies, such as ChiCTR2000037989, have evaluated its efficacy and safety compared to standard treatments like hydroxychloroquine for relieving symptoms such as dry mouth and eyes and improving overall disease status in adult patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Qingre Runzao Decoction.